CAR-T Cell Therapy in First Line for High Risk Diffuse Large B-Cell Lymphoma: Review of Efficacy and Cost-Effectiveness Against Standard of Care Chemo-Immunotherapy

Authors :: Usman Ali Akbar
Zaraq Rashid
Zarlish Rehman
Shehzad Alam
Zooha Altaf
Rana Usman Anwar
Adil Khan
Jafir Wakeel
Saad Farooq
Muhammad Haris Khan
Danish Safi
Arslan Inayat
Salah Ud Din Safi
Source :: Blood. 140:12052-12054
Publication Year :: 2022
Publisher :: American Society of Hematology, 2022.

Tools